Analysis of apoptosis-associated genes and pathways in oral cancer cells

Journal of Oral Pathology and Medicine

Volumn 35, Issue 3, 2006, Pages 146-154

  Gibson, Sandra ^a   Shillitoe, Edward J ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Apoptosis; BCL2; CD40; Microarray; Oral cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CD40 LIGAND; CD40 RECEPTOR; PACLITAXEL; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY 5; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN TU183; DNA MICROARRAY; DRUG EXPOSURE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KERATINOCYTE; MOUTH CANCER; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TNFRSF5 GENE;

ANTIGENS, CD40; APOPTOSIS; CELL LINE, TUMOR; EPIDERMIS; GENE EXPRESSION; HUMANS; KERATINOCYTES; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 33645224914     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2006.00398.x     Document Type: Article

References (42)

1. Min BM Woo KM Lee G et al. Terminal differentiation of normal human oral keratinocytes is associated with enhanced cellular TGF-beta and phospholipase C-gamma1 levels and apoptotic cell death. Exp Cell Res 1999 249 377 85.
2. Maruoka Y Harada H Mitsuyasu T et al. Keratinocytes become terminally differentiated in a process involving programmed cell death. Biochem Biophys Res Commun 1997 238 886 90.
3. Harada H Mitsuyasu T Seta Y et al. Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vitro. J Oral Pathol Med 1998 27 11 7.
4. Evan GI Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001 411 342 8.
5. Cory S Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002 2 647 56.
6. Frisch SM Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 1997 9 701 6.
7. Frisch SM Vuori K Kelaita D et al. A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA. J Cell Biol 1996 135 1377 82.
8. Zhang Y Lu H Dazin P et al. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis. J Biol Chem 2004 279 48342 9.
9. Firestone WM FitzGerald GB Wick MM. A comparison of the effects of antitumor agents upon normal human epidermal keratinocytes and human squamous cell carcinoma. J Invest Dermatol 1990 94 657 61.
10. Hail N Lotan R. Synthetic retinoid CD437 promotes rapid apoptosis in malignant human epidermal keratinocytes and G1 arrest in their normal counterparts. J Cell Physiol 2001 186 24 34.
11. Kok S Hong C Kuo M et al. Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes. Oral Oncol 2003 39 19 26.
12. Ghose A Fleming J El-Bayoumy K et al. Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways. Cancer Res 2001 61 7479 87.
13. Schmitt C Lowe S. Apoptosis and therapy. J Pathol 1999 187 127 37.
14. Li C Thompson CB. DNA damage, deamidation, and death. Science 2003 298 1346 7.
15. Schmitt C. Senescence, apoptosis and therapy - cutting the lifelines of cancer. Nat Rev Cancer 2003 3 286 95.
16. Sumantran VN Zhang R Lee DS et al. Differential regulation of apoptosis in normal versus transformed mammary epithelium by lutein and retinoic acid. Cancer Epidemiol Biomarkers Prev 2000 9 257 63.
17. Deverman BE Cook BL Manson SR et al. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 2002 111 51 62.
18. Gibson SA Pellenz C Hutchison RE et al. Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector. Clin Cancer Res 2000 6 213 22.
19. de la Fuente A Brazhnik P Mendes P. Linking the genes: inferring quantitative gene networks from microarray data. Trends Genet 2002 18 395 8.
20. Rebhan M Chalifa-Caspi V Prilusky J et al. GeneCards: integrating information about genes, proteins and diseases. Trends Genet 1997 13 163.
21. Swan E Jasser SA Holsinger F et al. Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer. Oral Oncol 2003 39 648 55.
22. Brazhnik P de la Fuente A Mendes P. Gene networks: how to put the function in genomics. Trends Biotechnol 2002 20 467 72.
23. Korsmeyer SJ Shutter JR Veis DJ et al. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993 4 327 32.
24. Bissonnette RP Echeverri F Mahboubi A et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992 359 552 4.
25. Kawai H Nie L Yuan Z. Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl. Mol Cell Biol 2002 22 6079 88.
26. Yang L Cao Z Yan H et al. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 2003 63 6815 24.
27. Kamer A Krebs L Hoghooghi S et al. Proliferative and apoptotic responses in cancers with special reference to oral cancer. Crit Rev Oral Biol Med 1999 10 58 78.
28. Rhodes D Barrette T Rubin M et al. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res 2002 62 4427 33.
29. Tan P Downey T Spitznagel E et al. Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res 2003 31 5676 84.
30. Jang T. Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma. Yonsei Med J 2002 43 304 8.
31. Tong A Papayoti M Netto G et al. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer. Clin Cancer Res 2001 7 691 703.
32. Bugajska U Georgopoulos N Southgate J et al. The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis. J Natl Cancer Inst 2002 94 1381 95.
33. Grdisa M. Influence of CD40 ligation on survival and apoptosis of B-CLL cells in vitro. Leuk Res 2003 27 951 6.
34. Posner M Cavacini L Upton MP et al. Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines. Clin Cancer Res 1999 5 2261 70.
35. Cao W Cavacini L Tillman K et al. CD40 function in squamous cell cancer of the head and neck. Oral Oncol 2005 41 462 9.
36. Kawakami K Tsukuda M Mizuno H et al. Alteration of the Bcl-2/Bax status of head and neck cancer cell lines by chemotherapeutic agents. Anticancer Res 1999 19 3927 32.
37. Tan G Heqing L Jiangbo C et al. Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells. Int J Cancer 2002 97 168 72.
38. Zhan Q Kontny U Iglesias M et al. Inhibitory effect of bcl-2 on p53-mediated transactivation following genotoxic stress. Oncogene 1999 14 297 304.
39. Hirano A Longo D Taub D et al. Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand. Blood 1999 93 2999 3007.
40. Gallagher N Eliopoulos A Agathangelo A et al. CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion. J Clin Pathol Mol Pathol 2002 55 110 20.
41. Hess S Engelmann H. A novel function of CD40: induction of cell death in transformed cells. J Exp Med 1996 183 159 67.
42. Ghosh M Crocker J Morris A. CD40 and Bcl2 expression in squamous cell carcinoma of the lung: correlation with apoptosis, survival, and other clinicopathological factors. J Pathol 1999 189 363 7.